Oct. 30, 2025
— Jeff Ward, Lehigh Valley News Briefs
OraSure keeps falling.
Shares (NASDAQ:OSUR) of the Bethlehem-based maker of diagnostic kits and other medical devices touched $2.72 on Thursday morning.
That means OraSure is trading at a discount of its about $3.20 cash-per-share as of June 30. The company has probably thrown some cash away on an ill-conceived buyback, but not that much. OraSure’s cash balance and balance sheet were the things the company had going for it.
This year, there have been Reuters reports of a potential cash offer for the company, and of an investor group seeking board representation. The stock jumps now and then but for years, it’s been heading down.
Based on the numbers, OraSure investors would have been better off stuffing their cash into a mattress.
Third-quarter financial results are due Nov. 5. Perhaps Chief Executive Carrie Eglinton Manner will have some good news, or perhaps some outside investor will come in and make an offer.
I’d like to see OraSure right itself. It’s an interesting local company, formerly SolarCare, a maker of sunscreen towels. It employs local people, and during the COVID-19 pandemic OraSure drew some federal money to the Lehigh Valley.
Wall Street is not as interested. I checked Zacks Investment Research, which listed only one estimate for the third quarter, and that projects a loss of 16 cents per share. The single revenue estimate is for $29.1 million for the quarter, down from last year’s number.
Here’s a link to the release about third-quarter results and the 5 p.m. conference call on Nov. 5.
Lehigh Valley News Briefs 